Global Pregnancy and Mother Care Technology Market Research Report - by Type (Devices, Software, Services); Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare); End-Use (Direct-to-Consumer, Hospitals, Fertility Clinics, Surgical Centres, Diagnostic Centres); Region Forecast 2024 - 2030

Market Size and Overview:

According to our research report, the global Pregnancy and Mother Care Technology market size was at USD 574.07 billion in 2023 and is expected to reach USD 1,410.22 billion by 2030. The global market is expected to witness a growth rate of 13.7% CAGR during the forecasted period from 2024 to 2030. 

The Pregnancy and Mother Care Technology market is subject to numerous variables, including elevated birth rates, changing lifestyles, and affordability. The market's expansion is propelled by the rising newborn population in emerging nations like China and India, coupled with an increasing emphasis on e-commerce. Urbanization has contributed to a higher percentage of nuclear families where both parents are employed, leading to increased per capita spending on infant and mother care. Among the array of baby care products available, pacifiers and breast pumps are notable examples. However, it's crucial to note that regular pacifier use may result in infections. The Pregnancy and Mother Care Technology sector are poised to benefit from heightened awareness of baby care and mother care products in emerging markets, along with the integration of technology into items like cribs, strollers, and toys.

The escalating incidence of chronic and infectious diseases among women is anticipated to drive demand for enhanced diagnosis and treatment options, thereby fostering market growth. Businesses are increasingly directing their efforts toward creating innovative engineering solutions to enhance women's safety and well-being. Advancements in women's wellness products, encompassing items such as tampons, breast pumps, and pelvic floor fitness devices, are also instrumental in propelling the industry forward.

Impact of COVID-19 on the Pregnancy and Mother Care Technology Market

Despite the seemingly low COVID-19 death rates in children and women of reproductive age, these groups might face disproportionate effects due to inefficient routine health services, particularly in low- and middle-income countries like India. Concerns about contracting the virus in healthcare facilities, a lack of confidence in the health system, and misconceptions about the disease's origins collectively create challenges that could impede progress in maternal and child health indicators. Addressing the impact of pandemic-prevention measures on maternal and child health, while ensuring the maintenance of essential health services during epidemic containment, presents a significant challenge. Even amid the risk of COVID-19 transmission, national programs must persist in delivering critical maternal and child services deemed essential for preserving lives.

MARKET DRIVERS

The advancement of digital healthcare is propelling the market forward.

Increased market demand for services like embryo screening, egg freezing, fertility, and others is a direct result of groundbreaking fem tech solutions. Additionally, the creation of wearable devices designed to monitor and track patient well-being is poised to enhance usage in the upcoming years. The expected availability of such technologically advanced devices during the projected period will significantly contribute to market growth.

The market is experiencing growth due to a heightened demand for maternity care applications.

Femtech finds application in various domains such as reproductive health, pregnancy and nursing care, pelvic and uterine health, general healthcare and wellness, among others. The pregnancy and nursing care segment dominate the market share. The market stands to benefit from the increasing demand for enhanced equipment and consumables used in pregnancy and nursing care. The introduction of contemporary nursing care gadgets is anticipated to positively influence market growth.

MARKET RESTRAINTS

Societal taboos surrounding women's health issues are impeding market progress.

Despite the pivotal role played by expanding AI advancements and collaborations with public healthcare agencies, market limitations arise from demographic factors, urban-rural disparities, and variations in population socioeconomic status. Additionally, the stigma associated with women's health, particularly in areas related to sexual health, birth control, menstruation, and fertility, poses a hindrance to the growth of the Pregnancy and Mother Care Technology sector.

In certain emerging regions, a lack of awareness about femtech products and applications is hindering market expansion.

Growing concerns about specific chemicals, coupled with a declining birth rate, are likely to serve as market limitations for the growth of prenatal care products in the forecasted period. The lack of awareness and accessibility to pregnancy-related goods in low-income nations constitutes a significant and pressing obstacle for the market.

Pregnancy and Mother Care Technology - by Type

• Devices
• Software
• Services

Within this segment of the Pregnancy and Mother Care Technology market, various devices, software, and services are encompassed. Notably, the software category is poised to exhibit the highest growth rate among the types. The increasing prevalence of chronic and infectious conditions in women is a significant factor driving demand for improved diagnostic and treatment options, contributing to the growth of this segment. Additionally, businesses are consistently innovating to introduce novel and technologically advanced methods for enhancing women's health and well-being. Innovations in women's health products such as tampons, breast pumps, and pelvic floor exercise devices are expected to play a pivotal role in fostering industry growth.

Pregnancy and Mother Care Technology - by Application

• Reproductive Health
• Pregnancy & Nursing Care
• Pelvic & Uterine Healthcare

In the forthcoming years, the Pregnancy & Nursing Care application category is anticipated to dominate the market, having held a substantial 40.2 percent share in 2020. The ascendancy of the pregnancy and nursing care market in 2021 can be attributed to the increasing demand for innovative products and consumables utilized during pregnancy and breastfeeding, aligning with consumer trends. The general healthcare and wellness segment is projected to be the fastest-growing, with an estimated growth rate of 16.0 percent. Heightened awareness among women regarding early disease detection is expected to drive demand for improved diagnostic and screening technologies, ensuring swift and accurate diagnoses. The utilization of femtech solutions is on the rise to achieve successful outcomes and mitigate delays in medical treatments or other health remedies, thus safeguarding patient safety.

Pregnancy and Mother Care Technology - by End-Use

• Direct-to-Consumer
• Hospitals
• Fertility Clinics
• Surgical Centres
• Diagnostic Centres

Conditions such as uterine fibroids, gynecological infections, and urinary incontinence significantly impact women, prompting them to seek accurate diagnosis at clinical facilities due to the availability of specialized technologies and experienced healthcare professionals. The increasing demand for precise and prompt diagnoses is expected to propel market growth. Innovations in fertility tracking apps, pregnancy monitoring solutions for home care, and other technologies tailored to meet women's needs are anticipated to drive segmental growth. Additionally, advancements in feminine hygiene products and the growing preference for tampons and menstrual cups over sanitary napkins are expected to contribute to market expansion.

Pregnancy and Mother Care Technology - by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

In North America, the Pregnancy and Mother Care Technology industry is projected to grow at a rate of 15.8 percent throughout the study period, driven by the increasing prevalence of women's disorders in the region. Enhanced focus on women's contributions to development and health education is expected to intensify competition for technologically creative solutions. Legislative emphasis on women's well-being and safety is poised to further support the growth of the femtech business in North America.

The Asia Pacific region is anticipated to witness the fastest growth at a rate of 16.1%. Populous countries like India and China, with a substantial pool of patients vulnerable to infectious and chronic diseases, will serve as the primary drivers of global industry expansion. The industry's commitment to providing reliable, high-quality, and user-friendly tools and solutions to enhance women's lives is expected to facilitate geographical expansion. Developments in China's healthcare system and advancements in femtech are likely to be advantageous for the industry, complemented by initiatives to promote female political leaders and empower a new generation of entrepreneurs in the field.

Pregnancy and Mother Care Technology by Company

The Pregnancy and Mother Care Technology market exhibits a concentrated landscape, primarily dominated by a limited number of small and medium-sized producers that collectively hold the majority of the global market share. These manufacturers are strategically positioned across the value chain, with leading companies boasting significant production facilities and active involvement in extensive research and development initiatives.

Key Companies:

1. Athena Feminine Technologies
2. Sustain Natural
3. Sera Prognostics
4. HeraMED
5. on Health
6. Totohealth
7. Minerva
8. Nuvo
9. Elvie
10. BioWink

Notable Events in the Pregnancy and Mother Care Technology Sector in Recent Times

Product Launches:

1. October 2021: Salignostics, a medical firm based in Jerusalem, announced the upcoming release of the world's first and only saliva-based rapid pregnancy test kit. This non-invasive method of pregnancy detection aims to provide precise results within minutes.
2. March 2021: Lia, a women-founded firm specializing in eco-friendly reproductive health and wellness products, launched the world's first biodegradable and flushable pregnancy test.
3. October 2020: Inne, a Berlin-based business, disclosed securing USD 8 million in Series A funding for its hormone-monitoring subscription platform dedicated to natural conception and fertility tracking. Blossom Capital led the Series A fundraising round.